Morgan Stanley Adjusts Price Target on Merck to $177 From $179
MT newswire2026/10/07 13:0709:07 AM EDT, 10/07/2026 (MT Newswires) -- Merck & Co (MRK) has an average rating of overweight and mean price target of $155.36, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Titan Mining, US Army advance strategic graphite processing plant in Alabama
Paxos Adds XRP to Crypto Brokerage as Institutional Access Expands
Ondo, Kakaopay Open Korean Stocks to Global Investors
$72.3B Bitcoin Giant Strategy Fuels Fresh Buy Rumors with Saylor’s Latest Post
Crypto prices
More
